52665-49-3 Usage
General Description
Furan-3-sulfonyl chloride, also known as 3-sulfonyl chloride furan, is a chemical compound with the molecular formula C4H3ClO2S. It is a colorless to light yellow liquid that is primarily used as a reagent in organic synthesis, particularly in the production of pharmaceuticals and agrochemicals. It is a highly reactive compound that is capable of forming covalent bonds with a variety of organic compounds, and it is widely used as an intermediate in the production of sulfonamides, which are important pharmacological agents. Furan-3-sulfonyl chloride is also known for its strong sulfonating ability, making it a valuable tool in the modification of organic molecules for various industrial applications. However, it should be handled with caution, as it is corrosive and can cause severe skin and eye irritation.
Check Digit Verification of cas no
The CAS Registry Mumber 52665-49-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,6,6 and 5 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 52665-49:
(7*5)+(6*2)+(5*6)+(4*6)+(3*5)+(2*4)+(1*9)=133
133 % 10 = 3
So 52665-49-3 is a valid CAS Registry Number.
InChI:InChI=1/C4H3ClO3S/c5-9(6,7)4-1-2-8-3-4/h1-3H
52665-49-3Relevant articles and documents
SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE
-
, (2010/12/01)
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.